Sunday, October 12, 2008 - 7:11AM EST

Clinical Trials

11. A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression.

Author
Frye MA; Grunze H; Suppes T; McElroy SL; Keck PE Jr; Walden J; Leverich GS; Altshuler LL; Nakelsky S; Hwang S; Mintz J; Post RM;
Institution
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, UCLA, Los Angeles, USA. mfrye@mayo.edu
Journal
Am J Psychiatry. 2007 Aug;164(8):1242-9.
Abstract URL
Click here to view abstract

12. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.

Author
Amsterdam JD; Shults J;
Institution
Department of Psychiatry, Depression Research Unit, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-3309, USA. jamsterd@mail.med.upenn.edu
Journal
J Clin Psychopharmacol. 2008 Apr;28(2):171-81.
Abstract URL
Click here to view abstract

13. Cognitive functioning and acute sedative effects of risperidone and quetiapine in patients with stable bipolar I disorder: a randomized, double-blind, crossover study.

Author
Harvey PD; Hassman H; Mao L; Gharabawi GM; Mahmoud RA; Engelhart LM;
Institution
Department of Psychiatry, Mt. Sinai School of Medicine, New York, NY, USA.
Journal
J Clin Psychiatry. 2007 Aug;68(8):1186-94.
Abstract URL
Click here to view abstract

14. Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder.

Author
Goldberg JF; Bowden CL; Calabrese JR; Ketter TA; Dann RS; Frye MA; Suppes T; Post RM;
Institution
Affective Disorders Program, Silver Hill Hospital, New Canaan, Connecticut 06840, USA. JFGoldberg@yahoo.com
Journal
Biol Psychiatry. 2008 Jan 1;63(1):125-30. Epub 2007 Jun 1.
Abstract URL
Click here to view abstract

15. Effectiveness of adjunctive antidepressant treatment for bipolar depression.

Author
Sachs GS; Nierenberg AA; Calabrese JR; Marangell LB; Wisniewski SR; Gyulai L; Friedman ES; Bowden CL; Fossey MD; Ostacher MJ; Ketter TA; Patel J; Hauser P; Rapport D; Martinez JM; Allen MH; Miklowitz DJ; Otto MW; Dennehy EB; Thase ME;
Institution
Bipolar Clinic and Research Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. gsachs@partners.org
Journal
N Engl J Med. 2007 Apr 26;356(17):1711-22. Epub 2007 Mar 28.
Abstract URL
Click here to view abstract

16. Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression.

Author
Baune BT; Caliskan S; Todder D;
Institution
Department of Psychiatry, James Cook University, Townsville, Australia. Bernhard.Baune@jcu.edu.au
Journal
Hum Psychopharmacol. 2007 Jan;22(1):1-9.
Abstract URL
Click here to view abstract

17. Lower weight gain with the orally disintegrating olanzapine than with standard tablets in first-episode never treated psychotic patients.

Author
Arranz B; San L; Duenas RM; Centeno M; Ramirez N; Salavert J; Del Moral E;
Institution
Hospital San Rafael, Barcelona, Spain.
Journal
Hum Psychopharmacol. 2007 Jan;22(1):11-5.
Abstract URL
Click here to view abstract

18. Association between illicit drug and alcohol use and first manic episode.

Author
Frank E; Boland E; Novick DM; Bizzarri JV; Rucci P;
Institution
Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh, 3811 O'Hara Street, Pittsburgh, PA 15213, USA. franke@msx.upmc.edu
Journal
Pharmacol Biochem Behav. 2007 Feb;86(2):395-400. Epub 2006 Dec 26.
Abstract URL
Click here to view abstract

19. A sham-controlled trial of the efficacy and safety of twice-daily rTMS in major depression.

Author
Loo CK; Mitchell PB; McFarquhar TF; Malhi GS; Sachdev PS;
Institution
School of Psychiatry, University of NSW and Black Dog Institute, Sydney, Australia. colleen.loo@unsw.edu.au
Journal
Psychol Med. 2007 Mar;37(3):341-9. Epub 2006 Dec 19.
Abstract URL
Click here to view abstract

20. A randomized, double-blind, placebo-controlled study of quetiapine in the treatment of bipolar I and II depression: improvements in quality of life.

Author
Endicott J; Rajagopalan K; Minkwitz M; Macfadden W;
Institution
New York State Psychiatric Institute, New York City, NY 10032, USA. je10@columbia.edu
Journal
Int Clin Psychopharmacol. 2007 Jan;22(1):29-37.
Abstract URL
Click here to view abstract
Pages: 1 2 3